Liquid ondansetron at triage showed no benefit over placebo for reducing observation time in pediatric gastroenteritis.
Ondansetron at Triage Doesn’t Speed ER Discharge for Kids
This randomized controlled trial enrolled 91 children aged 6 months to 17 years with gastroenteritis presenting with more than 3 vomiting ep…
Giving anti-vomiting medicine early didn't reduce ER observation time for kids with stomach infections, though the study was too small to co…
Electronic antiemetic device plus ondansetron improved delayed CINV response in 126 cancer patients.
A Wearable Buzz on Your Wrist May Ease Chemo Nausea
This single-centre randomized controlled trial enrolled 126 cancer patients receiving moderately or highly emetogenic chemotherapy. Particip…
A small device targeting an old acupressure point may give real relief from the days-long nausea that chemo drugs leave behind.
FDA Approves Ondansetron Injection, USP (ondansetron hydrochloride) for Prevention of Chemotherapy-Induced and Postoperative Nausea/Vomiting
FDA approves a new preservative-free injection to prevent nausea and vomiting from chemotherapy and surgery.
FDA approved ondansetron injection for prevention of nausea/vomiting associated with emetogenic cancer chemotherapy and postoperative nausea…
FDA approves a new preservative-free injection to prevent nausea and vomiting from chemotherapy and surgery.
Network meta-analysis compares 5-HT3 antagonists with or without dexamethasone for highly emetogenic chemotherapy-induced nausea and vomiting.
New analysis suggests palonosetron plus dexamethasone may reduce delayed vomiting in chemotherapy patients.
This network meta-analysis evaluated 5-hydroxytryptamine-3 (5-HT3) receptor antagonists with or without dexamethasone in patients undergoing…
Combining palonosetron with dexamethasone reduces delayed vomiting in chemotherapy patients better than other common drug options.
Ondansetron Slightly Prolongs QTc Interval in Pediatrics Without Dysrhythmia Risk
Is Ondansetron Safe for Kids? New Insights on Heart Health
Meta-analysis shows ondansetron increases QTc by 4.7 ms (95% CI 1.4-8.1) in healthy children, with no dysrhythmia risk.
While ondansetron slightly changes heart measurements in kids, serious rhythm problems are extremely rare, making it a safe option for treat…